Hostname: page-component-6b88cc9666-zff2w Total loading time: 0 Render date: 2026-02-12T06:59:55.124Z Has data issue: false hasContentIssue false

MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study – CORRIGENDUM

Published online by Cambridge University Press:  10 February 2026

Tor-Morten Kvam*
Affiliation:
Institute of Clinical Medicine, University of Oslo, Norway Nordre Østfold DPS, Østfold Hospital Trust, Grålum, Norway
Ivar W. Goksøyr
Affiliation:
Nordre Østfold DPS, Østfold Hospital Trust, Grålum, Norway
Justyna Rog
Affiliation:
Nordre Østfold DPS, Østfold Hospital Trust, Grålum, Norway
Inger-Tove Jentoft van de Vooren
Affiliation:
Nordre Østfold DPS, Østfold Hospital Trust, Grålum, Norway
Lowan Han Stewart
Affiliation:
Nordre Østfold DPS, Østfold Hospital Trust, Grålum, Norway
Ingrid Autran
Affiliation:
Nordre Østfold DPS, Østfold Hospital Trust, Grålum, Norway
Mark Berthold-Losleben
Affiliation:
Nordre Østfold DPS, Østfold Hospital Trust, Grålum, Norway Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway
Lynn Mørch-Johnsen
Affiliation:
Department of Psychiatry, Østfold Hospital Trust, Grålum, Norway Department of Clinical Research, Østfold Hospital Trust, Grålum, Norway
René Holst
Affiliation:
Department of Clinical Research, Østfold Hospital Trust, Grålum, Norway
Ingmar Clausen
Affiliation:
Nordre Østfold DPS, Østfold Hospital Trust, Grålum, Norway
Ole A. Andreassen
Affiliation:
Institute of Clinical Medicine, University of Oslo, Norway Oslo University Hospital, Oslo, Norway
*
Correspondence: Tor-Morten Kvam. Email: tor-morten.kvam@so-hf.no
Rights & Permissions [Opens in a new window]

Abstract

Information

Type
Corrigendum
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - SA
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-ShareAlike licence (https://creativecommons.org/licenses/by-sa/4.0/), which permits re-use, distribution, and reproduction in any medium, provided the same Creative Commons licence is used to distribute the re-used or adapted article and the original article is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of Royal College of Psychiatrists

Since this article’s publication, the authors have discovered and reported a minor error after analysis of follow-up data relating to one participant’s post-treatment Montgomery–Åsberg Depression Rating Scale (MADRS) score.

The error does not affect the reported number of responders or remitters or the MADRS scores among the nine participants without comorbid post-traumatic stress disorder. The error does not alter any of the study’s interpretation of the results, or the conclusions.

The corrected table is below:

Table 2 Overall summary of primary, secondary and selected exploratory efficacy outcomes

MADRS, Montgomery–Asberg Depression rating scale; SDS, Sheehan Disability Scale; BDI-II, Beck’s Depression Inventory-II; GAD-7, Generalised Anxiety Disorder-7; PCL-5, the Post-Traumatic Stress Disorder Checklist for DSM-5; BIS, Bergen Insomnia Scale; AUDIT, Alcohol Use Disorders Identification Test; DUDIT, Drug Use Disorder Identification Test.

a. All outcomes are exploratory unless otherwise noted.

b. Visit 3 (V3) for MADRS and SDS, screening for AUDIT and DUDIT and V4 for other outcome measures.

c. V13 for MADRS and SDS, V14 for other outcome measures.

The same corrected values should also be applied to the ‘Primary outcome’ section of the paper, on page 785.

References

Kvam, T-M, Goksøyr, IW, Rog, J, et al. MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study. The British Journal of Psychiatry. 2025; 227: 783–9.10.1192/bjp.2025.10320CrossRefGoogle ScholarPubMed
Figure 0

Table 2 Overall summary of primary, secondary and selected exploratory efficacy outcomes

This journal is not currently accepting new eletters.

eLetters

No eLetters have been published for this article.